JAMDA
July 10, 2025
Showing 1 - 10 of 112 results
JAMDA
June 14, 2025
Central Nervous System Polypharmacy Among People Living With Dementia
The Centers for Medicare and Medicaid Services Polypharmacy-CNS (Poly-CNS) quality metric identifies individuals taking multiple medications with central nervous system side effects. The Poly-CNS measure may reduce risky prescribing for persons living with dementia (PLWD).
JAMDA
April 13, 2025
Agreement of Medicare Part D and Minimum Data Set Reported Psychotropic Medication Use in Nursing Homes
Little evidence exists on the accuracy of the Minimum Data Set (MDS)–based medication items. We compared quarterly rates of antipsychotic, antidepressant, and hypnotic use between the MDS and Part D Prescription Drug Event file (PDE) in 2018.
JAMDA
March 21, 2025
High Anticholinergic Burden of Patients Hospitalized for Hip Fracture Reveals a Target for Deprescribing
Anticholinergic medications can produce harmful side effects, such as ataxia and delirium, in older adults. Older adults with hip fractures are particularly vulnerable, yet they are often prescribed these medications. This study aimed to evaluate the anticholinergic burden (ACB) before and after hospitaliz...
JAMDA
February 6, 2025
Antipsychotic Use in Older Adults with Dementia: Community and Nursing Facility Trends in Texas, 2015-2020
To assess recent trends in antipsychotic use among older adults with Alzheimer's disease and related dementias (ADRDs) according to their residential status and determine the factors associated with the use of antipsychotics.
JAMDA
January 10, 2025
Effects of Nursing Home Changes in Antipsychotic Use on Outcomes among Residents with Dementia
Little information exists on whether nationwide efforts to reduce antipsychotic use among nursing home (NH) residents with Alzheimer's disease and related dementias improved mortality and hospitalization outcomes for residents. Our objective was to examine the effect of NH decreases in antipsychotic u...
JAMDA
October 28, 2024
Reducing the Inappropriate Use of Antipsychotics in Long-Term Care: Strategies for Success
The inappropriate use of antipsychotic medications in older adults can reduce the quality of life and increase the risk of adverse drug interactions. To address this concern, a quality improvement study was implemented across 34 long-term care (LTC) homes in Ontario, Canada. The study aimed to reduce inapp...
Podcast
June 14, 2024
Tardive Dyskinesia: Risk Factors and Its Impact on Older Adults and Caregivers
Tune in with Dr. Amita Patel as she shares her insights into what tardive dyskinesia is, its risk factors, and its impact on older adults and caregivers, highlighting the importance of early recognition and management of this frequently underdiagnosed movement disorder in the long-term care setting. ...
JAMDA
June 2, 2024
Development of a Behavior-Change Intervention toward Benzodiazepine Deprescribing in Older Adults Living in Nursing Homes
We aimed to develop a context-specific intervention toward benzodiazepine deprescribing in nursing homes (NHs), with insights from behavior-change theories and involvement of stakeholders.
JAMDA
May 17, 2024
The Impact of Deprescribing Interventions on the Drug Burden Index and Other Outcomes: A Systematic Review
The Drug Burden Index (DBI) calculates a person's exposure to anticholinergic and sedative medications. We aimed to review randomized controlled trials (RCTs) of deprescribing interventions that reported the DBI as an outcome, their characteristics, effectiveness in reducing the DBI, and impact on oth...
